Table 1 Clinical baseline characteristics of HCC patients in TCGA and GEO cohorts
Variable | TCGA cohorts | GEO cohorts | ||
|---|---|---|---|---|
n = 371 | GSE10143, n = 80 | GSE76427, n=115 | ||
Age, year | 59.22 ± 13.42 | NA | 63.45 ± 12.68 | |
Gender | NA | NA | ||
Male | 119 | NA | 93 | |
Female | 252 | NA | 44 | |
Grade | NA | BCLC stage | ||
G1 | 55 | NA | 0 | 4 |
G2 | 180 | NA | A | 74 |
G3 | 123 | NA | B | 28 |
G4 | 13 | NA | C | 9 |
Stage | NA | |||
I | 174 | NA | 55 | |
II | 85 | NA | 35 | |
III | 86 | NA | 21 | |
IV | 5 | NA | 3 | |
Unknown | 21 | NA | 1 | |
AJCC-T | NA | |||
T1 | 184 | NA | NA | |
T2 | 92 | NA | NA | |
T3 | 81 | NA | NA | |
T4 | 13 | NA | NA | |
Unknown | 1 | NA | NA | |
AJCC-N | NA | |||
N0 | 256 | NA | NA | |
N1 | 4 | NA | NA | |
Nx | 110 | NA | NA | |
Unknown | 1 | NA | NA | |
AJCC-M | NA | |||
M0 | 270 | NA | NA | |
M1 | 4 | NA | NA | |
Mx | 97 | NA | NA | |
Overall survival | NA | |||
1-year | 84.6% | 98.6% | 88.7% | |
3-year | 72.3% | 88.6% | 84.3% | |
5-year | 67.4% | 78.8% | 80.7% | |
Survival status | ||||
Alive | 243 | 48 | 92 | |
Death | 128 | 32 | 23 | |